ABSTRACT
Identified first by Lancefield and Hare in 1935, the group G streptococcus occurs as commensals in the skin, pharynx, intestine, and vagina. It has been reported to cause a variety of human infections, such as sepsis, endocarditis, peritonitis, pharyngitis, and infective arthritis. Group G streptococcus sepsis could occur in chronic states such as malignancy, diabetes, alcoholics, neurologic disease, cardiovarscular disease, and end stage renal disease, however, there has been only a few case reports of endogenous endopthalmitis caused by group G streptococcus. We report herein endogenous endopthalmitis caused by group G streptococcus sepsis in 64-year-old man of alcoholic.
Subject(s)
Humans , Middle Aged , Alcoholics , Arthritis , Endocarditis , Endophthalmitis , Hares , Intestines , Kidney Failure, Chronic , Peritonitis , Pharyngitis , Pharynx , Sepsis , Skin , Streptococcus , VaginaABSTRACT
Identified first by Lancefield and Hare in 1935, the group G streptococcus occurs as commensals in the skin, pharynx, intestine, and vagina. It has been reported to cause a variety of human infections, such as sepsis, endocarditis, peritonitis, pharyngitis, and infective arthritis. Group G streptococcus sepsis could occur in chronic states such as malignancy, diabetes, alcoholics, neurologic disease, cardiovarscular disease, and end stage renal disease, however, there has been only a few case reports of endogenous endopthalmitis caused by group G streptococcus. We report herein endogenous endopthalmitis caused by group G streptococcus sepsis in 64-year-old man of alcoholic.
Subject(s)
Humans , Middle Aged , Alcoholics , Arthritis , Endocarditis , Endophthalmitis , Hares , Intestines , Kidney Failure, Chronic , Peritonitis , Pharyngitis , Pharynx , Sepsis , Skin , Streptococcus , VaginaABSTRACT
BACKGROUND/AIMS: The aims of this study were to determine subgoups of functional dyspesia and to evaluate the short-term effect of cisapride in patients with functional dyspepsia in Korea. METHODS: 1025 patients, with a mean age of 42.6 years, with symptoms of functional dyspepsia, were recruited consecutively and upper gastrointestinal symptoms were investigated by interview in 41 hospitals in Korea. In an open, multicenter trial, 1025 patients received Smg of cisapride three times a day (TID) for at least .2 weeks for the treatment of symptoms of functional dyspepsia. When necessary, the dose of cisapride was increased to 10mg TID and the duration of therapy was extended to 4 weeks. RESULTS: The most frequently reported symptoms of functional dyspepsia were epigastric discomfort or fullness (85%), bloating (70%), belching (53%), early satiety (52%) and epigastric pain (46%) retrospectively. Subgroups of functional dyspepsia were as follows; dysmotility-like 73.5%, ulcer-like 39.7%, reflux-like 13.0%, and unspecified dyspepsia 14.0%. However, 33.2% of subjects with functional dyspepsia could be classified into more than one subgroup. Upper gastrointestinal symptoms were decreased to average 50.3% (range; 42.2 to 59.2%) after 2 weeks of cisapride treatment and to 25% (19.2 to 29.9%) after 4 weeks. cisapride therapy resulted in good or excellent improvement in 59.0% of the patients after two weeks, in 75% of patients after 4 weeks. Adverse events were occurred in 52 patients (5.8% of all patients), most commonly, loose stools or diarrhea (3.5%), abdominal pain (1.1%), and dizziness (0.3%). The majority of adverse events was mild and transient in nature and led to premature discontinuation of treatment in 4 patients. CONCLUSIONS: Although the majorities of patients with functional dyspepsia have dysmotility like symptoms in Korea, there is such overlap among the dyspepsia subgroups. Most patients responded well to a short therapeutic trial with cisapride without significant side effects.
Subject(s)
Humans , Abdominal Pain , Cisapride , Diarrhea , Dizziness , Dyspepsia , Eructation , Korea , Retrospective StudiesABSTRACT
Insulinoma is rare functioning islet cell tumor of pancreas and its main feature is frequent attacks of hypoglycemia. Because of frequent seizure, the disease is occasionally mistook as epilepy. We experienced a case of insulinoma with dilantin toxicity in a 45 year old patient who had been treated with dilantin for 7 years. Selective splenic arteriogram showed 0.8cm mass in the tail of pancreas which was proven insulin secreting tumor on histiopathological examination. After operation no more seizure attack was detected and her blood sugar level was well maintained within normal range. This case might provide an insight that the possibility of insulinoma should be considered in patient with episodic neurobehavioral dysfunction such as epilepsy.